Format

Send to

Choose Destination
See comment in PubMed Commons below
J Biomol Screen. 2015 Aug;20(7):921-6. doi: 10.1177/1087057115587458. Epub 2015 May 18.

The Bacterial Sec Pathway of Protein Export: Screening and Follow-Up.

Author information

1
Department of Medicine, University of Washington, Seattle, WA, USA crowther@uw.edu.
2
Department of Medicine, University of Washington, Seattle, WA, USA.
3
Department of Biochemistry, University of Washington, Seattle, WA, USA.

Abstract

Most noncytoplasmic bacterial proteins are exported through the SecYEG channel in the cytoplasmic membrane. This channel and its associated proteins, collectively referred to as the Sec pathway, have strong appeal as a possible antibiotic drug target, yet progress toward new drugs targeting this pathway has been slow, perhaps due partly to many researchers' focus on a single component, the SecA ATPase. Here we report on a pathway-based screen in which beta-galactosidase (β-gal) activity is trapped in the cytoplasm of Escherichia coli cells if translocation through SecYEG is impaired. Several hit compounds passed a counterscreen distinguishing between β-gal overexpression and impaired β-gal export. However, the most extensively characterized hit gave limited E. coli growth inhibition (EC(50) ≥ 400 µM), and growth inhibition could not be unambiguously linked to the compound's effect on the Sec pathway. Our study and others underscore the challenges of finding potent druglike hits against this otherwise promising drug target.

KEYWORDS:

SecE; SecG; SecY; drug development; protein translocation; translocase

PMID:
25987586
DOI:
10.1177/1087057115587458
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Atypon
    Loading ...
    Support Center